Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies. The pattern of inattention, ...

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies.

Stimulant medications and non-stimulant medications affect brain chemistry through different mechanisms”— Dr. Stanford ...

NEW YORK, July 12, 2024 /PRNewswire/ -- The global central nervous system (CNS) stimulant drugs market size is estimated to grow by USD 6.48 billion from 2023-2027, according to Technavio. The market ...

A research team of the Center for Brain Research at the Medical University of Vienna has identified a specific cell group in the brain responsible for shifts in the sleep-wake rhythm caused by ...

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, ...

Lisdexamfetamine dimesylate 30 mg, 50 mg, 70 mg; caps. After oral administration, lisdexamfetamine is rapidly absorbed from the GI tract and is converted to the active drug dextroamphetamine.

Understood reports ADHD meds may raise heart risks; lifestyle factors like sleep issues and weight gain also affect heart health in those with ADHD.

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

Long-term use of stimulant medication for attention-deficit/hyperactivity disorder (ADHD) does not appear to cause lasting changes in brain development, according to a study published in Progress in ...